LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 616 | 1,057 | 0 | 0 | 0 |
| Gross Profit | 616 | 1,057 | N/A | N/A | N/A |
| Operating Expenses | 78,988 | 43,026 | 21,340 | 17,941 | 10,739 |
| Operating Income | -78,372 | -41,969 | -21,340 | -17,941 | -10,739 |
| Other Income | 187 | 57 | 27 | 6 | 3,002 |
| Pre-tax Income | -78,185 | -41,912 | -21,313 | -17,935 | -7,737 |
| Net Income Continuous | -78,185 | -41,912 | -21,313 | -17,935 | -7,737 |
| Net Income | $-78,185 | $-41,912 | $-21,313 | $-17,935 | $-7,737 |
| EPS Basic Total Ops | -4.54 | -2.68 | -2.00 | -12.16 | -41.77 |
| EPS Basic Continuous Ops | -4.54 | -2.68 | -2.00 | -11.65 | -37.93 |
| EPS Diluted Total Ops | -4.54 | -2.68 | -2.00 | -12.16 | -41.77 |
| EPS Diluted Continuous Ops | -4.54 | -2.68 | -2.00 | -11.65 | -37.93 |
| EPS Diluted Before Non-Recurring Items | -4.54 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-77,642 | $-41,622 | $-21,323 | $-17,936 | $-10,739 |